iSpecimen Inc.
ISPC- Exchange
- Nasdaq
- Industry
- Services-Commercial Physical & Biological Research
- SEC CIK
- 0001558569
No open-market purchases or sales by iSpecimen Inc. insiders were filed in the last 90 days; 8 institutions reported holding it in 13F filings for Q2 2026, worth $152.0K in total; no superinvestor holds it.
Q2 2026 vs. Q1 2026
How the institutions holding iSpecimen Inc. changed between Q1 2026 and Q2 2026.
All holders in Q2 2026All holders in Q1 2026
| Measure | Q1 2026 | Q2 2026 | Change |
|---|---|---|---|
| Holders | 12 | 8 | −4 |
| Shares | 531.6K | 65.0K | −466.6K (−87.8%) |
| Value | $83.5K | $152.0K | +$68.5K (+82.1%) |
New holders (2)
Institutions that held iSpecimen Inc. at the end of Q2 2026 but not at the end of Q1 2026.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| IFP Advisors, Inc | 8,200 | $1.51K | 0.00% |
| Caitong International Asset Management Co., Ltd | 2 | $5 | 0.00% |
Sold out (6)
Institutions that held iSpecimen Inc. at the end of Q1 2026 and filed for Q2 2026 without it.
| Institution | Shares, Q1 2026 | Value, Q1 2026 |
|---|---|---|
| Geode Capital Management, LLC | 313,098 | $49.2K |
| Citadel Advisors LLC | 50,471 | $7.92K |
| Vanguard Fiduciary Trust Co | 28,170 | $4.42K |
| StoneX Group Inc. | 19,710 | $3.09K |
| Gill Capital Partners, LLC | 15 | $2 |
| Sachetta, LLC | 2 | – |